COMMUNIQUÉS West-GlobeNewswire

FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder
25/03/2019
Company announcement, Helsinki, 25 March 2019 at 9.00 am (EET) FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder Nexstim Plc (NXTMH:HEX, [...]
Philips convenes the 2019 Annual General Meeting of Shareholders
25/03/2019
March 25, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2019 Annual General Meeting of Shareholders (AGM) and publishes the agenda with explanatory notes. The agenda includes [...]
PDMR Dealing
25/03/2019
LONDON, March 25, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Oasmia Pharmaceutical AB receives positive opinion from the European Medicines Agency to add efficacy data to the approved Apealea® product information
25/03/2019
Uppsala, Sweden, March 25, 2019 – Oasmia Pharmaceutical AB (NASDAQ: OASM) today announce that the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a type II variation application [...]
The Alliance for Regenerative Medicine Announces Final Agenda for 2019 Cell & Gene Meeting on the Mediterranean
25/03/2019
The Alliance for Regenerative Medicine Announces Final Agenda for 2019 Cell & Gene Meeting on the Mediterranean WASHINGTON, D.C. – March 25, 2019 The Alliance for Regenerative Medicine (ARM), the international [...]
CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam
25/03/2019
More Than 1.3 Million New Cases of Prostate Cancer Worldwide in 2018 LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will be exhibiting and presenting [...]
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
25/03/2019
Studies Shared by Physicians from Marseilles Hospital & Portuguese Institute of Oncology LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical [...]
Néovacs renforce sa structure financière
25/03/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS RENFORCE SA STRUCTURE FINANCIÈRE: ÉMISSION D'«ORNANE» POUR UN MONTANT MAXIMUM DE €10M, SANS BONS DE SOUSCRIPTION D'ACTIONS Paris et Boston, le [...]
Neovacs reports full-year 2018 Financial results and provides corporate update
25/03/2019
RESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS REPORTS FULL-YEAR 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE KEY OPINION LEADERS VALIDATE THE THERAPEUTIC POTENTIAL OF IFNα KINOID IN LUPUS TREATMENT [...]
Néovacs annonce ses résultats annuels 2018 et fait le point sur ses activités
25/03/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES RÉSULTATS ANNUELS 2018 ET FAIT LE POINT SUR SES ACTIVITÉS VALIDATION PAR LES EXPERTS SCIENTIFIQUES DU POTENTIEL THÉRAPEUTIQUE DE L’ [...]
Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth
25/03/2019
New multichannel consumer campaign will feature QBREXZA patients Campaign to drive consumer awareness of QBREXZA QBREXZA is the first and only FDA-approved, once-daily, topical prescription treatment indicated for [...]
REVA Receives Interim Funding Commitment and Announces Leadership Changes
25/03/2019
SAN DIEGO, March 24, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that it has secured a letter of commitment for up to $3 million of debt financing to fund operations on an [...]
MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multiple Sclerosis at the 71st American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania
25/03/2019
LA JOLLA, Calif., March 24, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated Superior Efficacy and Comparable Safety and Tolerability of TransCon™ hGH to a Daily Growth Hormone
24/03/2019
- Oral presentation of results in pediatric growth hormone deficiency on behalf of investigators at ENDO 2019 - - Patient group acknowledges importance of once-weekly therapy to address overall impact of GHD - [...]
Developing Better Athletes through Optometry
24/03/2019
ANDERSON, S.C., March 24, 2019 (GLOBE NEWSWIRE) -- There's a new game in town called Sports Vision EyeQ, by RightEye. It is a comprehensive way to measure, analyze, and correct eye movements, giving vision that goes [...]
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO
23/03/2019
New Orleans, US , 23 March 2019 - Oral semaglutide 7 mg and 14 mg demonstrated superior HbA 1c and body weight reductions compared to Januvia ® (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA 1c [...]
Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
23/03/2019
-Post-hoc analysis suggests abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concurrent osteoarthritis, at high risk for fracture- -Preclinical studies provide explanations for [...]
InspireMD Provides Amended Disclosure
22/03/2019
TEL AVIV, Israel, March 22, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
Healthcare Special Opportunities Fund Announces March 2019 Quarterly Distribution
22/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- ( TSX: MDS.UN ) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]

Pages